Mol Psychiatry:南方科大刘东课题组等合作鉴定新ADHD致病基因

2017-05-19 佚名 生物帮

近日,国际学术权威刊物自然出版集团旗下子刊、神经精神病学顶尖杂志《Molecular Psychiatry》在线发表了南方科技大学生物系刘东课题组的一篇研究论文。ADHD(注意缺陷多动障碍)是常见的儿童行为障碍,其症状可持续至成年,常与多种精神疾病共患,对个人、家庭和社会造成诸多不良影响。ADHD的核心缺陷是执行抑制功能的神经元出现问题,引起多动、冲动和注意缺陷。我们团队早前提出神经元发育缺陷是A

近日,国际学术权威刊物自然出版集团旗下子刊、神经精神病学顶尖杂志《Molecular Psychiatry》在线发表了南方科技大学生物系刘东课题组的一篇研究论文。

ADHD(注意缺陷多动障碍)是常见的儿童行为障碍,其症状可持续至成年,常与多种精神疾病共患,对个人、家庭和社会造成诸多不良影响。ADHD的核心缺陷是执行抑制功能的神经元出现问题,引起多动、冲动和注意缺陷。我们团队早前提出神经元发育缺陷是ADHD的重要致病原因假说,现通过广泛收集病人样本,对ADHD执行抑制功能的全基因组(汉族人群)数据的详细分析(GWAS)和生物信息学验证,发现MICALL2与人的ADHD症状密切关联,MICALL2调节神经元轴突发育。

作为模式动物,斑马鱼研究已具备较为完善的遗传操作手段。斑马鱼与人类基因同源性强(87%),具有获得大量实验样本,养殖成本低,实验操作简便等优势。通过降低斑马鱼MICALL2同源基因micall2b的表达,我们发现幼鱼一些脑神经元发育异常,引起多动-冲动行为,表明抑制功能缺陷。有趣的是,该异常行为可被治疗ADHD药物缓解/纠正(图一)。因此,MICALL2是一个新ADHD致病基因。

卢青、张樱腊共同完成斑马鱼ADHD疾病模型建立和分析。我们拟运用同样的技术手段筛选ADHD致病候选基因,并建立突变体鱼系。在成功建立ADHD斑马鱼模型基础上,将开展ADHD治疗药物的筛选工作。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1792050, encodeId=41651e9205026, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Nov 18 03:15:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307597, encodeId=8fa3130e597c8, content=<a href='/topic/show?id=459f19e855' target=_blank style='color:#2F92EE;'>#ADHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1978, encryptionId=459f19e855, topicName=ADHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488505, encodeId=430a14885050e, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200208, encodeId=54ee20020894, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=445f1740270, createdName=meiliwuxian, createdTime=Sat May 20 05:52:17 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1792050, encodeId=41651e9205026, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Nov 18 03:15:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307597, encodeId=8fa3130e597c8, content=<a href='/topic/show?id=459f19e855' target=_blank style='color:#2F92EE;'>#ADHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1978, encryptionId=459f19e855, topicName=ADHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488505, encodeId=430a14885050e, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200208, encodeId=54ee20020894, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=445f1740270, createdName=meiliwuxian, createdTime=Sat May 20 05:52:17 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2017-05-21 lg.zhao
  3. [GetPortalCommentsPageByObjectIdResponse(id=1792050, encodeId=41651e9205026, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Nov 18 03:15:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307597, encodeId=8fa3130e597c8, content=<a href='/topic/show?id=459f19e855' target=_blank style='color:#2F92EE;'>#ADHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1978, encryptionId=459f19e855, topicName=ADHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488505, encodeId=430a14885050e, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200208, encodeId=54ee20020894, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=445f1740270, createdName=meiliwuxian, createdTime=Sat May 20 05:52:17 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1792050, encodeId=41651e9205026, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Nov 18 03:15:00 CST 2017, time=2017-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307597, encodeId=8fa3130e597c8, content=<a href='/topic/show?id=459f19e855' target=_blank style='color:#2F92EE;'>#ADHD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1978, encryptionId=459f19e855, topicName=ADHD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488505, encodeId=430a14885050e, content=<a href='/topic/show?id=b569864e51e' target=_blank style='color:#2F92EE;'>#致病基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86475, encryptionId=b569864e51e, topicName=致病基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d1a8427162, createdName=wfang548, createdTime=Sun May 21 05:15:00 CST 2017, time=2017-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200208, encodeId=54ee20020894, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=445f1740270, createdName=meiliwuxian, createdTime=Sat May 20 05:52:17 CST 2017, time=2017-05-20, status=1, ipAttribution=)]
    2017-05-20 meiliwuxian

    学习一下

    0

相关资讯

J Child Psychol Psychiat:父母的教养方式影响儿童间的欺凌行为

Normal 0 false 10 pt 0 2 false false false EN-US ZH-CN X-NONE

Int J Epidemiol:对乙酰氨基酚可能不再是妊娠期安全药物

孕期可以使用的药物本来就很少,再一细分到止痛药,更是少的可怜;还好,价廉物美的家庭必备药对乙酰氨基酚被认为是安全的。美国约有65%的准妈妈使用这种药物。遗憾的是,一项新的研究表明,产前暴露于对乙酰氨基酚可能与后代的自闭症和注意缺陷多动障碍(ADHD)有关,至此以后它可能不那么安全了。西班牙巴塞罗那的环境流行病学研究中心的研究人员Claudia Avella-Garcia和同事招募了2644名妊娠1

JAMA Pediatr:ADHD儿童和青少年服用兴奋药物显著降低骨量

鼠研究揭示交感神经系统激活导致骨量减少。用于治疗注意缺陷/多动障碍(ADHD)的兴奋药物增加交感神经张力,并可能影响骨重建。由于骨量增加是在成年早期完成的,所以评估兴奋剂对生长中的儿童骨密度的影响是至关重要的。来自美国的研究人员开展了一项研究,该研究的目的是探讨在儿童和青少年人群中,兴奋药物的使用和骨量之间的关系。该横断面分析使用了在2005年1月1日至2010年12月31日期间国家健康和营养调查

Labour Econ:药物治疗ADHD好处多多

根据最近的研究,对注意缺陷多动障碍(ADHD)患者进行药物治疗可降低青少年性病、滥用药物和受伤的可能性。来自英国普林斯顿大学健康中心的Anna Chorniy博士和同事们对150000例ADHD儿童进行了研究,探究药物治疗对怀孕、青少年性病、滥用药物、受伤及处方用药医生偏好依从性等方面的影响。调查结果表明,ADHD患者的药物治疗与短期和长期严重程度负面健康问题的发病率下降有很强的相关性。在10年的

AAOS 2016:ADHD治疗药物会导致患儿骨骼发育不良

2016年美国矫形外科医师学会年会(AAOS)上,美国陆军外科研究所的Jessica Rivera博士提出ADHD治疗药物会导致患儿骨骼发育不良。 CDC指出,2011年美国约有640万名儿童被诊断出患有注意缺陷多动障碍(ADHD)。 ADHD儿童易出现注意力不集中、白日梦、健忘、坐立不安、说话尖酸刻薄、粗心、难以与他人相处。尽管研究人员目前正在研究ADHD的成因和风险因素,研究表明基因起到了重要

SHP465-306治疗成人ADHD是安全有效的

根据最近一项长达4周的随机、双盲、多中心研究结果,Shire开发的三珠混合苯丙胺盐胶囊三珠混合苯丙胺盐胶囊对注意缺陷多动障碍(ADHD)是安全和有效的。该研究纳入了275名年龄在18岁到55岁之间的ADHD患者,患者随机接受12.5 mg或37.5 mg的SHP465-306,以及安慰剂对照。在4周时,与安慰剂组相比,接受12.5 mg SHP465-306患者的ADHD评定量表总分最小二乘均数差